Zynex inc   (ZYXI)
Other Ticker:  
Price: $12.5700 $0.27 2.195%
Day's High: $12.98 Week Perf: -8.52 %
Day's Low: $ 12.26 30 Day Perf: 7.8 %
Volume (M): 350 52 Wk High: $ 14.75
Volume (M$): $ 4,393 52 Wk Avg: $9.78
Open: $12.26 52 Wk Low: $6.88

 Market Capitalization (Millions $) 454
 Shares Outstanding (Millions) 36
 Employees 335
 Revenues (TTM) (Millions $) 186
 Net Income (TTM) (Millions $) 16
 Cash Flow (TTM) (Millions $) 19
 Capital Exp. (TTM) (Millions $) 1

Zynex Inc
Zynex Inc. is a medical device manufacturing company based in Lone Tree, Colorado, U.S.A. It was founded in 1996 by Thomas Sandgaard, who is currently the CEO and Chairman of the Board of Directors. Zynex specializes in the design, manufacture, and distribution of electrotherapy devices and other medical devices for pain management, rehabilitation, and neurological diagnostics.

The company has a broad range of products that cater to the needs of various patient populations. Its electrotherapy devices, which are its primary product line, are designed to relieve pain, treat muscle spasms, and promote tissue healing using electric currents. The electrotherapy devices include the NexWave, which is a non-invasive nerve stimulation system that provides pain relief, and the InWave, which is used for muscle rehabilitation and toning.

Zynex also manufactures and distributes the NeuroMove, a device that uses electrical stimulation to help people with paralysis and other neurological disorders improve their muscle function, and the Blood Volume Monitor, which is used by physicians to monitor blood volume during surgery and other medical procedures.

In addition to its product offerings, Zynex provides a range of services to healthcare providers, including training, support, and consulting services. The company has a team of experienced clinicians who assist healthcare providers in the selection, use, and maintenance of its medical devices.

Zynex has established itself as a leading player in the medical device industry, with its products being used by healthcare providers in the United States, Canada, and Mexico. The company has a strong commitment to research and development, and it invests heavily in clinical trials and other research initiatives to improve the quality and efficacy of its products.

Overall, Zynex Inc. is a highly reputable and innovative medical device manufacturing company that is committed to improving patient outcomes through the design and distribution of high-quality, safe, and effective medical devices.

   Company Address: 9655 Maroon Cir Englewood 80112
   Company Phone Number: 703-4906   Stock Exchange / Ticker: NASDAQ ZYXI
   ZYXI is expected to report next financial results on March 12, 2024.


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Zynex Inc

Zynex Inc Reports 20.2% Increase in Revenue for Q3 2023, with Net Income Declining 11.11% due to Strategic Sales Focus

Zynex Inc Announces Financial Results for Q3 2023: Revenue Rises 20.2% but Net Income Drops 11.11%
Zynex Inc, a leading Medical Equipment & Supplies company, recently reported its financial results for the third quarter of 2023. Despite witnessing a remarkable 20.219% increase in revenue during the period, the company experienced a decline in net income per share, falling from $0.13 to $0.10. This decrease in net income can be attributed to the company's intensified focus on improving sales during the quarter.
Although the net profit per share showed growth of 11.11% from $0.09 to $0.10, it was unable to match the previous year's Q3 earnings. The financials revealed that Zynex Inc generated $44.95 million in revenue, which presents an 11.041% increase from the same period a year ago. However, the net income of $3.594 million in the third quarter of 2023 represented a significant decline of 26.25% compared to the $4.873 million the company earned in the corresponding period in 2022.

Zynex Inc

Zynex Inc. Reports Q2 2023 Income Surge of 12.5%, Highlighting Rapid EPS and Revenue Growth Amid Industry Challenges

Zynex Inc, a company operating in the Medical Equipment & Supplies sector, has demonstrated impressive growth and resilience in the second quarter of 2023. Despite the challenging conditions faced by many companies in the industry, Zynex Inc managed to significantly increase its earnings per share (EPS) and revenue.
In the second quarter of 2023, Zynex Inc reported an EPS of $0.09 per share, representing a 12.5% growth compared to $0.08 per share in the previous year. Furthermore, the company's earnings per share grew rapidly by 125% from $0.04 per share in the prior financial reporting period. This significant increase in EPS reflects the company's strong financial performance and ability to generate profits.


Zynex Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com